{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:31Z","timestamp":1791856111408,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"10-13","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.steroids.2003.08.008","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T02:52:36Z","timestamp":1067309556000},"page":"891-905","source":"Crossref","is-referenced-by-count":113,"title":["Conception and pharmacodynamic profile of drospirenone"],"prefix":"10.1016","volume":"68","author":[{"given":"Walter","family":"Elger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhard","family":"Pollow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Qing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hillisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2003.08.008_BIB1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF01681040","article-title":"Neue per os-wirksame weibliche Keimdr\u00fcsenhormon-derivate: 17-aethinyl-oestradiol und pregnen-in-on-3-ol-17","volume":"26","author":"Inhoffen","year":"1938","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.steroids.2003.08.008_BIB2","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/ja01645a010","volume":"76","author":"Djerassi","year":"1954","journal-title":"J. Am. Chem. Soc."},{"issue":"3\/4","key":"10.1016\/j.steroids.2003.08.008_BIB3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0960-0760(95)00214-6","article-title":"Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application","volume":"55","author":"Elger","year":"1995","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1071\/RD01029","article-title":"Estrogen sulfamates: a new approach to oral estrogen therapy","volume":"13","author":"Elger","year":"2001","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.steroids.2003.08.008_BIB5","doi-asserted-by":"crossref","unstructured":"Larsson-Cohn U. Some biochemical consequences of post-menopausal hormone replacement treatment. In: Van Keep PA, Utian WH, Vermeulen A, editors. The controversial climacteric. Lancaster: MTP Press Limited; 1981. p. 29\u201337.","DOI":"10.1007\/978-94-011-7253-0_4"},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0010-7824(96)00194-1","article-title":"Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women","volume":"54","author":"Baumann","year":"1996","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.steroids.2003.08.008_BIB7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","article-title":"Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol","volume":"151","author":"Goebelsmann","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.steroids.2003.08.008_BIB8","first-page":"673","article-title":"Biologic effects of various doses of ethinyl estradiol in postmenopausal women","volume":"59","author":"Mandel","year":"1982","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.steroids.2003.08.008_BIB9","doi-asserted-by":"crossref","unstructured":"Campbell S, Whitehead MI. Potency and hepato-cellular effects of oestrogens after oral, percutaneous, and subcutaneous administration. In: Van Keep PA, Utian WH, Vermeulen A, editors. The controversial climacteric. Lancaster: MTP Press Limited; 1981. p. 103\u201325.","DOI":"10.1007\/978-94-011-7253-0_12"},{"issue":"2","key":"10.1016\/j.steroids.2003.08.008_BIB10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5122(95)00950-7","article-title":"The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors","volume":"23","author":"Tikkanen","year":"1996","journal-title":"Maturitas"},{"issue":"1A","key":"10.1016\/j.steroids.2003.08.008_BIB11","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"98","author":"Darney","year":"1995","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.steroids.2003.08.008_BIB12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0039-128X(69)80007-3","article-title":"Anti-androgenic activity of spironolactone","volume":"14","author":"Steelman","year":"1969","journal-title":"Steroids"},{"issue":"Suppl 3","key":"10.1016\/j.steroids.2003.08.008_BIB14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14730782.2000.12288985","article-title":"Yasmin\u2014a new oral contraceptive, a new progestogen: the reasons why","volume":"5","author":"Mansour","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"5","key":"10.1016\/j.steroids.2003.08.008_BIB15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/jcem-15-10-1194","article-title":"The metabolic effects of progesterone in man","volume":"15","author":"Landau","year":"1955","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2003.08.008_BIB17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0010-7824(92)90121-9","article-title":"Dihydrospirorenone (ZK30595): a novel synthetic progestagen\u2014characterization of binding to different receptor proteins","volume":"46","author":"Pollow","year":"1992","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.steroids.2003.08.008_BIB18","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1021\/jm00112a022","article-title":"Aldosterone antagonists. 4. Synthesis and activities of steroidal 6,6-ethylene-15,16-methylene 17-spirolactones","volume":"34","author":"Nickisch","year":"1991","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.steroids.2003.08.008_BIB19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/jm50001a002","article-title":"Aldosterone antagonists. 1. Synthesis and activities of 6 beta,7 beta:15 beta,16 beta-dimethylene steroidal spirolactones","volume":"28","author":"Nickisch","year":"1985","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.steroids.2003.08.008_BIB20","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.steroids.2003.08.008_BIB22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00045415-199811000-00012","article-title":"The sexual dimorphism of high blood pressure","volume":"6","author":"Calhoun","year":"1998","journal-title":"Cardiol. Rev."},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB23","first-page":"198","article-title":"High blood pressure in women","volume":"42","author":"Calhoun","year":"1997","journal-title":"Int. J. Fertil. Womens Med."},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(95)00153-2","article-title":"Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease","volume":"52","author":"Godsland","year":"1995","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.steroids.2003.08.008_BIB26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/jmcc.1999.0963","article-title":"Extra-adrenal mineralocorticoids and cardiovascular tissue","volume":"31","author":"Slight","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.steroids.2003.08.008_BIB27","first-page":"1024","article-title":"Aldosterone antagonists in congestive heart failure [in process citation]","volume":"3","author":"Soberman","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.steroids.2003.08.008_BIB28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199909023411009","article-title":"Aldosterone and spironolactone in heart failure","volume":"341","author":"Weber","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.steroids.2003.08.008_BIB29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0039-128X(00)00205-1","article-title":"Corticosteroid receptor mRNA expression in the brains of patients with epilepsy","volume":"65","author":"Watzka","year":"2000","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1210\/er.19.3.269","article-title":"Brain corticosteroid receptor balance in health and disease","volume":"19","author":"De Kloet","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.steroids.2003.08.008_BIB31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0079-6123(08)60780-3","article-title":"Resolving a mystery: progress in understanding the function of adrenal steroid receptors in hippocampus","volume":"100","author":"McEwen","year":"1994","journal-title":"Prog. Brain Res."},{"issue":"9","key":"10.1016\/j.steroids.2003.08.008_BIB32","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1210\/en.136.9.3800","article-title":"Regulation of rat mineralocorticoid receptor expression in neurons by progesterone","volume":"136","author":"Castren","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.steroids.2003.08.008_BIB33","first-page":"95","article-title":"Brain corticosteroid receptor balance and homeostatic control","volume":"12","author":"DeKloet","year":"1991","journal-title":"Front. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB34","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(95)03559-P","article-title":"Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies","volume":"111","author":"Roland","year":"1995","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.steroids.2003.08.008_BIB35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0306-4530(00)00006-8","article-title":"Increased activity of the hypothalamus\u2013pituitary\u2013adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone","volume":"25","author":"Heuser","year":"2000","journal-title":"Psychoneuroendocrinology"},{"issue":"13","key":"10.1016\/j.steroids.2003.08.008_BIB36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(00)00677-4","article-title":"The brain mineralocorticoid receptor: greedy for ligand, mysterious in function","volume":"405","author":"Reul","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB37","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1210\/jc.82.4.1106","article-title":"Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary\u2013adrenal activity in human sleep","volume":"82","author":"Born","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.steroids.2003.08.008_BIB38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1365-2826.2000.00555.x","article-title":"Selective blockade of the mineralocorticoid receptor impairs hypothalamic\u2013pituitary\u2013adrenal axis expression of habituation","volume":"12","author":"Cole","year":"2000","journal-title":"J. Neuroendocrinol."},{"issue":"5","key":"10.1016\/j.steroids.2003.08.008_BIB39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000054384","article-title":"Mineralocorticoid receptor also modulates basal activity of hypothalamus\u2013pituitary\u2013adrenocortical system in humans","volume":"68","author":"Deuschle","year":"1998","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.steroids.2003.08.008_BIB40","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1210\/jc.86.7.3176","article-title":"Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans","volume":"86","author":"Arvat","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1C","key":"10.1016\/j.steroids.2003.08.008_BIB41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0022-4731(83)90010-9","article-title":"Synthesis and activities of anti-aldosterones","volume":"19","author":"Laurent","year":"1983","journal-title":"J. Steroid. Biochem."},{"issue":"2","key":"10.1016\/j.steroids.2003.08.008_BIB42","first-page":"459","article-title":"Progestogens with antimineralocorticoid activity","volume":"35","author":"Losert","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.steroids.2003.08.008_BIB43","unstructured":"Elger W, Beier S, Mannesmann G, Schillinger E. Pr\u00e4parate zur Kontrazeption und zur Behandlung gyn\u00e4kologischer St\u00f6rungen. Germany patent DE0003022337A1a; 1982."},{"key":"10.1016\/j.steroids.2003.08.008_BIB44","unstructured":"Beier S, Elger W, Nishino Y, Wiechert R. Dihydrospirorenone as an antiandrogen. Patent official-gazette-of-the-United-States-patent-and-trademark-office-patents, vol. 1191, no. 5. ISSN: 0098-1133; 1996. p. 3478."},{"key":"10.1016\/j.steroids.2003.08.008_BIB45","unstructured":"Elger W, Beier S. \u00dcberlegungen zur Bedeutung unterschiedlicher hormonaler Wirkungsspektren von Gestagenen. In: Hammerstein J, editor. Proceedings of the Internationales Symposium, Aktuelle Aspekte der hormonalen Kontrazeption, Berlin, 1982 February 13; Hammerstein, Amsterdam. p. 9\u201327."},{"issue":"6683","key":"10.1016\/j.steroids.2003.08.008_BIB46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/30775","article-title":"Atomic structure of progesterone complexed with its receptor","volume":"393","author":"Williams","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2003.08.008_BIB47","unstructured":"Tripos Inc. SYBYL. Tripos Inc. Hanley Road, Suite 303, St. Louis, MO; 1999."},{"key":"10.1016\/j.steroids.2003.08.008_BIB48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1113\/jphysiol.1934.sp003217","article-title":"Assay of progestogen","volume":"83","author":"McPhail","year":"1934","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0010-7824(92)90134-F","article-title":"Influence of different progestogens on blood pressure of non-anaesthetized male spontaneously hypertensive rats","volume":"46","author":"Berger","year":"1992","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.steroids.2003.08.008_BIB50","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/0002-9378(93)90299-X","article-title":"Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia","volume":"169","author":"Yallampalli","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.steroids.2003.08.008_BIB51","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/oxfordjournals.humrep.a019209","article-title":"Regulation of vascular adaptation during pregnancy and post-partum: effects of nitric oxide inhibition and steroid hormones","volume":"11","author":"Liao","year":"1996","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13625180008500376","article-title":"Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol","volume":"5","author":"Rosenbaum","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"6","key":"10.1016\/j.steroids.2003.08.008_BIB53","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin\u2013aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2003.08.008_BIB55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-73-4-837","article-title":"Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin\u2013aldosterone system in normal women","volume":"73","author":"Oelkers","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2003.08.008_BIB57","unstructured":"Elger W, Steinbeck H, Schillinger E, Losert W, Beier S. Endocrine-pharmacological profile of gestodene. In: Elstein M, editor. Gestodene. Development of a new gestodene-containing low-dose oral contraceptive. Casterton Hall, Carnforth: Parthenon Publishing; 1987. p. 19\u201333."},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1210\/endo-78-3-628","article-title":"Development of a vagina in male rats by inhibiting androgen receptors with an anti-androgen during the critical phase of organogenesis","volume":"78","author":"Neumann","year":"1966","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2003.08.008_BIB59","first-page":"271","article-title":"Recherches sur la differenciation sexuelle de l\u2019embryon de lapin: III. Role des gonades foetales dans la differenciation sexuelle somatique","volume":"36","author":"Jost","year":"1946","journal-title":"Arch. Anat. micr. Morph. exp."},{"key":"10.1016\/j.steroids.2003.08.008_BIB60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/endo-75-3-428","article-title":"Antagonism of androgenic and antiandrogenic agents in their action on the rat fetus","volume":"75","author":"Neumann","year":"1964","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1677\/joe.0.0360347","article-title":"The effect of the anti-androgen 1,2-alpha-methylene-6-chloro-delta-4,6-pregnadiene-17-alpha-ol-3,20-dione-17-alpha-acetate (cyproterone acetate) on the development of the mammary glands of male foetal rats","volume":"36","author":"Neumann","year":"1966","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.steroids.2003.08.008_BIB62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4684-3219-0_18","article-title":"Aspects of steroidal influence on fetal development","volume":"27","author":"Steinbeck","year":"1972","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.steroids.2003.08.008_BIB63","first-page":"337","article-title":"Aspects of androgen-dependent events as studied by antiandrogens","volume":"26","author":"Neumann","year":"1970","journal-title":"Recent. Prog. Horm. Res."},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB64","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","article-title":"Effect of an oral contraceptive containing drospirenone on the renin\u2013angiotensin\u2013aldosterone system in healthy female volunteers","volume":"14","author":"Oelkers","year":"2000","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.steroids.2003.08.008_BIB65","first-page":"359","article-title":"Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism","volume":"9","author":"Shiau","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"Suppl. 4","key":"10.1016\/j.steroids.2003.08.008_BIB66","first-page":"88","article-title":"Mineralocorticoid and antimineralocorticoid effects of various progestagens on electrogenic Na+ transport in rat distal colon in vitro","volume":"126","author":"Krattenmacher","year":"1992","journal-title":"Acta. Endocrinol. (Copenh)"},{"issue":"3","key":"10.1016\/j.steroids.2003.08.008_BIB67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0091-3057(96)00244-4","article-title":"Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats","volume":"56","author":"Smythe","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.steroids.2003.08.008_BIB68","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1210\/en.139.6.2718","article-title":"Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic\u2013pituitary\u2013adrenal axis activity","volume":"139","author":"Spencer","year":"1998","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.steroids.2003.08.008_BIB69","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1210\/jc.83.9.3339","article-title":"The role of mineralocorticoid receptors in hypothalamic\u2013pituitary\u2013adrenal axis regulation in humans","volume":"83","author":"Young","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"23","key":"10.1016\/j.steroids.2003.08.008_BIB70","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0024-3205(96)00549-8","article-title":"Type II (glucocorticoid) receptors mediate fast-feedback inhibition of the hypothalamic\u2013pituitary\u2013adrenal axis in man","volume":"59","author":"Cooney","year":"1996","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.steroids.2003.08.008_BIB71","first-page":"3176","article-title":"Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans","volume":"86","author":"Arvat","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 3","key":"10.1016\/j.steroids.2003.08.008_BIB72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/14730782.2000.12288988","article-title":"The acceptability of a novel oral contraceptive containing drospirenone and its effect on well-being","volume":"5","author":"Boschitsch","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"2","key":"10.1016\/j.steroids.2003.08.008_BIB73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB74","first-page":"14","article-title":"A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms","volume":"47","author":"Brown","year":"2002","journal-title":"J. Reprod. Med."},{"issue":"2","key":"10.1016\/j.steroids.2003.08.008_BIB75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"issue":"Suppl. 2","key":"10.1016\/j.steroids.2003.08.008_BIB76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/09513599609045657","article-title":"Effects of drospirenone on blood pressure and heart rate in rats measured by highly sensitive radiometry","volume":"10","author":"Krattenmacher","year":"1996","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB77","first-page":"6","article-title":"Drospirenone: a new progestogen with antimineralocorticoid properties in a monophasic oral contraceptive","volume":"7","author":"Oelkers","year":"2002","journal-title":"Gynaecol. Forum"},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB78","first-page":"83","article-title":"The renin\u2013aldosterone system and drospirenone","volume":"16","author":"Oelkers","year":"2002","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2003.08.008_BIB79","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/13625180008500407","article-title":"A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers","volume":"5","author":"Blode","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"1","key":"10.1016\/j.steroids.2003.08.008_BIB80","first-page":"27","article-title":"Cinical experiences with Yasmin","volume":"7","author":"Foidart","year":"2002","journal-title":"Gynaecol. Forum"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X03001697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X03001697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T05:09:21Z","timestamp":1704949761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X03001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":80,"journal-issue":{"issue":"10-13","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0039128X03001697"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2003.08.008","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}